PEDIATRICS Vol. 99 No. 2 February 1997, pp. 289-299

AMERICAN ACADEMY OF PEDIATRICS:
Therapy for Children With Invasive Pneumococcal Infections

This statement provides guidelines for therapy of children with serious infections possibly caused by Streptococcus pneumoniae. Resistance of invasive pneumococcal strains to penicillin, cefotaxime, and ceftriaxone has increased over the past few years. Reports of failures of cefotaxime or ceftriaxone in the treatment of children with meningitis caused by resistant S pneumoniae necessitates a revision of Academy recommendations. For nonmeningeal infections, modifications of the initial therapy need to be considered only for patients who are critically ill and those who have a severe underlying or potentially immunocompromising condition or patients from whom a highly resistant strain is isolated. Because vancomycin is the only antibiotic to which all S pneumoniae strains are susceptible, its use should be restricted to minimize the emergence of vancomycin-resistant organisms. Patients with probable aseptic (viral) meningitis should not be treated with vancomycin. These recommendations are subject to change as new information becomes available.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Statement of reaffirmation:

AAP Publications Retired and Reaffirmed

Pediatrics 114: 1126-1126. [Full Text]

This article has been cited by other articles:

				S. J. Alter Pneumococcal Infections Pediatr. Rev., May 1, 2009; 30(5): 155 - 164. [Full Text] [PDF]

				S. Ribes, F. Taberner, A. Domenech, C. Cabellos, F. Tubau, J. Linares, P. F. Viladrich, and F. Gudiol Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae J. Antimicrob. Chemother., May 1, 2006; 57(5): 931 - 936. [Abstract] [Full Text] [PDF]

				S. C. Buckingham, J. A. McCullers, J. Lujan-Zilbermann, K. M. Knapp, K. L. Orman, and B. K. English Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis Pediatrics, May 1, 2006; 117(5): 1688 - 1694. [Abstract] [Full Text] [PDF]

				Pneumococcal Infections Red Book, January 1, 2006; 2006(1): 525 - 537. [Full Text]

				A. P. Johnson, N. Potz, P. Waight, U. Gungabissoon, D. M. Livermore, R. Pebody, E. Miller, and R. C. George Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004 J. Antimicrob. Chemother., December 1, 2005; 56(6): 1181 - 1182. [Full Text] [PDF]

				M. R. Haase Acute Bacterial Meningitis in Children Journal of Pharmacy Practice, December 1, 2004; 17(6): 392 - 406. [Abstract] [PDF]

				K. L. O'Brien and M. Santosham Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases Am. J. Epidemiol., April 1, 2004; 159(7): 634 - 644. [Abstract] [Full Text] [PDF]

				J. A. Finkelstein, S. S. Huang, J. Daniel, S. L. Rifas-Shiman, K. Kleinman, D. Goldmann, S. I. Pelton, A. DeMaria, and R. Platt Antibiotic-Resistant Streptococcus pneumoniae in the Heptavalent Pneumococcal Conjugate Vaccine Era: Predictors of Carriage in a Multicommunity Sample Pediatrics, October 1, 2003; 112(4): 862 - 869. [Abstract] [Full Text] [PDF]

				Index of Suspicion Pediatr. Rev., September 1, 2003; 24(9): 311 - 316. [Full Text] [PDF]

				H. L. Keyserling, R. L. Sinkowitz-Cochran, J. M. Harris II, G. L. Levine, J. D. Siegel, B. H. Stover, S. A. Lau, and W. R. Jarvis Vancomycin Use in Hospitalized Pediatric Patients Pediatrics, August 1, 2003; 112(2): e104 - 111. [Abstract] [Full Text] [PDF]

				Pneumococcal Infections Red Book, January 1, 2003; 2003(1): 490 - 500. [Full Text]

				P McMaster, P McIntyre, R Gilmour, L Gilbert, A Kakakios, and C Mellis The emergence of resistant pneumococcal meningitis--implications for empiric therapy Arch. Dis. Child., September 1, 2002; 87(3): 207 - 210. [Abstract] [Full Text] [PDF]

				H. Marcovitch Atoms Arch. Dis. Child., September 1, 2002; 87(3): 173 - 173. [Full Text]

				K. McIntosh Community-Acquired Pneumonia in Children N. Engl. J. Med., February 7, 2002; 346(6): 429 - 437. [Full Text] [PDF]

				J. N. Reis, S. M. Cordeiro, S. J. Coppola, K. Salgado, M. G. S. Carvalho, L. M. Teixeira, T. A. Thompson, R. R. Facklam, M. G. Reis, and A. I. Ko Population-Based Survey of Antimicrobial Susceptibility and Serotype Distribution of Streptococcus pneumoniae from Meningitis Patients in Salvador, Brazil J. Clin. Microbiol., January 1, 2002; 40(1): 275 - 277. [Abstract] [Full Text] [PDF]

				S. B. Freedman, A. Marrocco, J. Pirie, and P. T. Dick Predictors of Bacterial Meningitis in the Era After Haemophilus influenzae Arch Pediatr Adolesc Med, December 1, 2001; 155(12): 1301 - 1306. [Abstract] [Full Text] [PDF]

				N. Anton, R. Blazquez, J. L. Gomez-Garces, and J. I. Alos Study of vancomycin tolerance in 120 strains of Streptococcus pneumoniae isolated in 1999 in Madrid, Spain J. Antimicrob. Chemother., June 1, 2001; 47(6): 902 - 903. [Full Text] [PDF]

				N. E. Rosenstein, B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes Meningococcal Disease N. Engl. J. Med., May 3, 2001; 344(18): 1378 - 1388. [Full Text] [PDF]

				W J Steinbach and A K Shetty Use of the diagnostic bacteriology laboratory: a practical review for the clinician Postgrad. Med. J., March 1, 2001; 77(905): 148 - 156. [Full Text]

				G. D. Overturf, the Committee on Infectious Diseases, Committee on Infectious Diseases, 1999-2000, Ex-Officio, Liaisons, Consultant, and Staff Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis Pediatrics, August 1, 2000; 106(2): 367 - 376. [Abstract] [Full Text]

				J. D. Heffelfinger, S. F. Dowell, J. H. Jorgensen, K. P. Klugman, L. R. Mabry, D. M. Musher, J. F. Plouffe, A. Rakowsky, A. Schuchat, C. G. Whitney, et al. Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance: A Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group Arch Intern Med, May 22, 2000; 160(10): 1399 - 1408. [Abstract] [Full Text] [PDF]

				E. O. Mason Jr, L. B. Lamberth, N. L. Kershaw, B. L. T. Prosser, A. Zoe, and P. G. Ambrose Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis J. Antimicrob. Chemother., May 1, 2000; 45(5): 623 - 631. [Abstract] [Full Text] [PDF]

				J. M. McLure A 9-Month-Old Boy with Fever and Lethargy Clinical Pediatrics, May 1, 2000; 39(5): 295 - 298. [PDF]

				J. I. Harwell and R. B. Brown The Drug-Resistant Pneumococcus: Clinical Relevance, Therapy, and Prevention Chest, February 1, 2000; 117(2): 530 - 541. [Abstract] [Full Text] [PDF]

				C. M. Gerber, M. Cottagnoud, K. Neftel, M. G. Tauber, and P. Cottagnoud Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro J. Antimicrob. Chemother., January 1, 2000; 45(1): 63 - 68. [Abstract] [Full Text] [PDF]

				G. Overturf Shortage of aqueous penicillin G prompts CDC to approve alternatives AAP News, January 1, 2000; 16(1): 14 - 16. [Full Text] [PDF]

				F. Fitoussi, C. Doit, P. Geslin, and E. Bingen Killing Activities of Trovafloxacin Alone and in Combination with beta -Lactam Agents, Rifampin, or Vancomycin against Streptococcus pneumoniae Isolates with Various Susceptibilities to Extended-Spectrum Cephalosporins at Concentrations Clinically Achievable in Cerebrospinal Fluid Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2372 - 2375. [Abstract] [Full Text]

				C. Sabella and J. Goldfarb Penicillin-Resistant Pneumococcal Infections Clinical Pediatrics, October 1, 1999; 38(10): 609 - 610. [PDF]

				P. K. Coyle Glucocorticoids in Central Nervous System Bacterial Infection Arch Neurol, July 1, 1999; 56(7): 796 - 801. [Abstract] [Full Text] [PDF]

				L. P. Jetté and C. Sinave Use of an Oxacillin Disk Screening Test for Detection of Penicillin- and Ceftriaxone-Resistant Pneumococci J. Clin. Microbiol., April 1, 1999; 37(4): 1178 - 1181. [Abstract] [Full Text]

				J. S. Abramson and L. B. Givner Bacterial Resistance Due to Antimicrobial Drug Addiction Among Physicians: Time for a Cure! Arch Fam Med, January 1, 1999; 8(1): 79 - 80. [Full Text] [PDF]

				T. Q. Tan, E. O. Mason Jr, W. J. Barson, E. R. Wald, G. E. Schutze, J. S. Bradley, M. Arditi, L. B. Givner, R. Yogev, K. S. Kim, et al. Clinical Characteristics and Outcome of Children With Pneumonia Attributable to Penicillin-susceptible and Penicillin-nonsusceptible Streptococcus pneumoniae Pediatrics, December 1, 1998; 102(6): 1369 - 1375. [Abstract] [Full Text] [PDF]

				M. Arditi, E. O. Mason Jr, J. S. Bradley, T. Q. Tan, W. J. Barson, G. E. Schutze, E. R. Wald, L. B. Givner, K. S. Kim, R. Yogev, et al. Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use Pediatrics, November 1, 1998; 102(5): 1087 - 1097. [Abstract] [Full Text]

				S. L. Kaplan and E. O. Mason Jr. Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae Clin. Microbiol. Rev., October 1, 1998; 11(4): 628 - 644. [Abstract] [Full Text] [PDF]

				S. L. Kaplan, E. O. Mason Jr, W. J. Barson, E. R. Wald, M. Arditi, T. Q. Tan, G. E. Schutze, J. S. Bradley, L. B. Givner, K. S. Kim, et al. Three-Year Multicenter Surveillance of Systemic Pneumococcal Infections in Children Pediatrics, September 1, 1998; 102(3): 538 - 545. [Abstract] [Full Text] [PDF]

				G. R. Cabrera, J. D. Fortenberry, B. L. Warshaw, C. R. Chambliss, J. C. Butler, and B. G. Cooperstone Hemolytic Uremic Syndrome Associated With Invasive Streptococcus pneumoniae Infection Pediatrics, April 1, 1998; 101(4): 699 - 699. [Full Text] [PDF]

				P. J. Chesney, N. A. Halsey, S. M. Marcy, V. Quagliarello, and W. M. Scheld Treatment of Bacterial Infections N. Engl. J. Med., September 11, 1997; 337(11): 793 - 794. [Full Text]